The Dangers of Hymenotomy for Imperforate Hymen: A Case of Iatrogenic Pelvic Inflammatory Disease with Pyosalpinx

article OA: closed CC0
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-10

This case report details iatrogenic pelvic inflammatory disease with pyosalpinx resulting from hymenotomy surgery for an imperforate hymen.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BackgroundComplications associated with imperforate hymen include cyclical abdominal pain, acute urinary retention, endometriosis, and even iatrogenic infections.CaseA 14-year-old young woman was diagnosed with an imperforate hymen, hematocolpos, and right hematosalpinx. A hymenotomy was performed, followed by a hymenectomy 3 days later. On postoperative day 7, she was admitted for pelvic inflammatory disease with a right pyosalpinx. The infection was refractory to intravenous gentamicin, ampicillin, and clindamycin so the patient underwent computed tomography-guided drainage of the pyosalpinx. Two days later, she was discharged home in good condition.Summary and conclusionSmall incisions and punctures into imperforate hymens without immediate definitive management should be avoided because inoculation of the newly introduced bacteria can ascend the gynecologic tract and lead to serious infections.

My notes (saved in your browser only)

MeSH descriptors

Colpotomy Hematocolpos Hymen Menstruation Disturbances Salpingitis Adolescent Colpotomy Congenital Abnormalities Drainage Drainage Female Hematocolpos Hematocolpos Humans Hymen Hymen Iatrogenic Disease Menstruation Disturbances Menstruation Disturbances Salpingitis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (22)

Source provenance

europepmc
last seen: 2026-07-28T06:14:09.330459+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:22:54.901233+00:00
License: CC0 · commercial use OK